Endpoint Preclinical

Endpoint Preclinical is a dedicated consulting network that specializes in streamlining and optimizing preclinical research for a diverse clientele, including CROs, pharmaceutical companies, biotech firms, medical device manufacturers, and academic laboratories. By eliminating administrative overhead and the complexities of managing multiple subcontractors, Endpoint Preclinical offers a single point of contact for comprehensive services. Their expertise spans surgical model development, advanced data analysis, training, and regulatory support, allowing research teams to concentrate on scientific advancement while they manage logistics.

Led by experienced professionals like CEO Cole McLarty and COO Andy Henton, Endpoint Preclinical is committed to delivering world-class support and ethical standards, ensuring that clients receive exceptional service. The company’s mission is to accelerate research by simplifying operations, from study design to vendor invoicing. With a vision to become a premier provider of preclinical research services, Endpoint Preclinical fosters long-term partnerships with technology providers and scientific institutions, aiming to advance discovery and innovation in the life sciences.